|
Market Closed -
Euronext Paris
16:55:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.6900 EUR | -2.27% |
|
0.00% | +400.00% |
| 08-24 | Valerio Therapeutics to Buy Etherna Immunotherapies in EUR30 Million Deal | MT |
| 08-17 | Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 410M | - | - | - | - | - |
| 1,001B | |||||
| 642B | - | - | - | ||
| 451B | |||||
| 340B | |||||
| 263B |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
